Background: Polycystic ovary syndrome (PCOS) is a multifactorial, heterogeneous, endocrine-metabolic disorder that commonly affects women at their reproductive age. PCOS is a complex syndrome characterized by chronic oligo-or anovulation, menstrual irregularities, hyperandrogenism, infertility, and polycystic ovarian morphologic features. The aim of the work WAS to evaluate the effect of vitamin D3 supplementation on insulin resistance, and visceral fat thickness in vitamin D3 deficient women with polycystic ovarian syndrome. Methods: Patients were allocated randomly into 2 groups: Group I: 30 women received 50.000 Iu of oral vitamin D3 (Cholecalciferol) (Breva) once weekly for (12) weeks. Group II (placebo group): 30 women received placebo capsules once weekly for (12) weeks. Trans-abdominal US and transvaginal US examination were performed for detailed ovary imaging Results: The difference in the glucose tolerance profile after treatment. There was a statistically significant difference between both groups regarding the mean fasting blood sugar levels (p =0.001), where the mean FBS in the intervention group was (79.60±9.464), while that of the placebo group was (89.67±9.181). Moreover, the HOMA-IR level varied significantly (p=0.017), where in the intervention group the mean level was (2.99±0.621), compared to a mean of (3.59±1.179) in the placebo group., none of the mean hormonal levels varied significantly among the intervention group from before to after treatment, except for the mean 25-hydroxy-vitamin D level (p= <0.001), which increased from (13.26±7.203) before treatment, to (26.76±15.531) after treatment. Conclusion:In conclusion, Vitamin D supplementation in an oral dose of 50.000 IU of vitamin D3 (Cholecalciferol) once weekly for (12) weeks among women with PCOS significantly increased serum 25OHD levels, and significantly decrease insulin resistance and visceral fat thickness no potential effect was detected on BMI, waist circumference (WC)and waist to hip Ratio.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.